Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elevance HealthMEX:ELV 75 Debt-to-Equity is 0.69 as of Jun. 2026, which is 5% above its 10-year median of 0.66. GuruFocus rates MEX:ELV with a GF Score™ of 75/100 and a GF Value™ of MXN7,839.79 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 14 Healthcare Plans companies, Elevance Health ranks better than 57.14% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Elevance Health's Debt-to-Equity or its related term are showing as below:
MEX:ELV'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.6 Med: 0.66 Max: 0.76
Current: 0.69
During the past 13 years, the highest Debt-to-Equity Ratio of Elevance Health was 0.76. The lowest was 0.60. And the median was 0.66.
MEX:ELV's Debt-to-Equity is ranked better than 57.14% of 14
companies
in the Healthcare Plans industry
Industry Median: 0.725
vs MEX:ELV: 0.69
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Elevance Health Debt-to-Equity Related Terms
Elevance Health Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Elevance Health's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ELV vs CI, HUM, CNC: Debt-to-Equity Comparison
For the Healthcare Plans subindustry, Elevance Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health Debt-to-Equity vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Elevance Health's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (MEX:ELV) has a Debt-to-Equity of 0.69 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Elevance Health and its competitors. This is near median its historical median of 0.66. Over the past decade, Elevance Health's Debt-to-Equity has ranged from 0.60 to 0.76. According to the industry distribution chart, Elevance Health ranks #6 out of 14 companies in the Healthcare Plans industry, placing it in the top 42.9%.
Is Elevance Health's Debt-to-Equity too high?
Elevance Health's current Debt-to-Equity of 0.69 is near median its 10-year median of 0.66. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 0.76. The Healthcare Plans industry median Debt-to-Equity is 0.73. Elevance Health's value of 0.69 is 4.8% below this industry median. Based on the distribution chart, Elevance Health ranks #6 out of 14 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Elevance Health has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Debt-to-Equity compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #6 out of 14 companies for Debt-to-Equity. This puts Elevance Health in the upper half of its industry. The industry median Debt-to-Equity is 0.73. Elevance Health's value of 0.69 is 4.8% below this benchmark. Historically, Elevance Health's own Debt-to-Equity has ranged from 0.60 to 0.76 over the past decade. While the company's 10-year median is 0.66 vs. the industry median of 0.73, Elevance Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Plans company?
The median Debt-to-Equity among Healthcare Plans companies is 0.73, based on 14 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current Debt-to-Equity of 0.69 is 4.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median Debt-to-Equity is 0.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current Debt-to-Equity is 0.69, which is near median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN7,839.79, compared to a current price of MXN6,449.00 — trading 17.7% below its estimated fair value. The current Debt-to-Equity is 0.69, which is near median its 10-year median of 0.66 and 4.8% below the Healthcare Plans industry median of 0.73. Elevance Health's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current Debt-to-Equity is 0.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (MEX:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of MXN6,449.00 is trading 17.7% below its estimated GF Value™ of MXN7,839.79.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for MEX:ELV:
Debt-to-Equity: 0.69 (near median its 10-year median of 0.66)
GF Value™: MXN7,839.79 vs. price of MXN6,449.00 (17.7% below fair value)
Industry Position: 4.8% below the Healthcare Plans median (#6 of 14)
No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
75GF Score
Get the complete analysis for MEX:ELV
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELV has been successfully added to your 
